BackZhengye Biotechnology Holding Limited Overview

Zhengye Biotechnology Holding Limited Total Current Liabilities

Track Zhengye Biotechnology Holding Limited's total current liabilities ($120M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$120.48M
11.35% YoYΔ $-15.43M vs prior year quarter

Peer average

Loading

Zhengye Biotechnology Holding Limited Total Current Liabilities History

Loading

Zhengye Biotechnology Holding Limited vs. peers: Total Current Liabilities Comparison

Loading

Zhengye Biotechnology Holding Limited Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Zhengye Biotechnology Holding Limited (ZYBT) FAQ

Zhengye Biotechnology Holding Limited posts a total current liabilities of $120M as of December 2025. That compares with $140M in the prior-year period — down 11.4% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Zhengye Biotechnology Holding Limited's total current liabilities was $140M. The latest reading is $120M — a 11.4% year-over-year decrease (period ending December 2025). Use the history and growth charts on this page for a longer lookback.

Total Current Liabilities is one piece of Zhengye Biotechnology Holding Limited's financial statement story. At $120M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for ZYBT's total current liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Zhengye Biotechnology Holding Limited's other metric pages and overview cover the third.